Glial and Axonal Body Fluid Biomarkers Are Related to Infarct Volume, Severity, and Outcome

2004, Epidemiology of stroke, 13 Sugawara, 2002, Effects of global ischemia duration on neuronal, astroglial, oligodendroglial, and microglial reactions in the vulnerable hippocampal CA1 subregion in rats, J Neurotrauma, 19, 85, 10.1089/089771502753460268 Dugan, 2004, Astrocyte mitochondria in vitro models of ischemia, J Bioenerg Biomembr, 36, 317, 10.1023/B:JOBB.0000041761.61554.44 Giffard, 2000, The electrogenic sodium bicarbonate cotransporter: Developmental expression in rat brain and possible role in acid vulnerability, J Neurosci, 20, 1001, 10.1523/JNEUROSCI.20-03-01001.2000 Steiner, 2007, Evidence for a wide extra-astrocytic distribution of S100B in human brain, BMC Neurosci, 8, 2, 10.1186/1471-2202-8-2 da Rocha, 2006, Role of serum S100B as a predictive marker of fatal outcome following isolated severe head injury or multitrauma in males, Clin Chem Lab Med, 44, 1234, 10.1515/CCLM.2006.218 Kleindienst, 2006, A critical analysis of the role of the neurotrophic protein S100B in acute brain injury, J Neurotrauma, 23, 1185, 10.1089/neu.2006.23.1185 Routsi, 2006, Increased levels of serum S100B protein in critically ill patients without brain injury, Shock, 26, 20, 10.1097/01.shk.0000209546.06801.d7 Lynch, 2004, Novel diagnostic test for acute stroke, Stroke, 35, 57, 10.1161/01.STR.0000105927.62344.4C Korfias, 2006, Serum S-100B protein as a biochemical marker of brain injury: A review of current concepts, Curr Med Chem, 13, 3719, 10.2174/092986706779026129 Sindic, 1982, Assessment of damage to the central nervous system by determination of S-100 protein in the cerebrospinal fluid, J Neurol Neurosurg Psychiatry, 45, 1130, 10.1136/jnnp.45.12.1130 Unden, 2005, Raised serum S100B levels after acute bone fractures without cerebral injury, J Trauma, 58, 59, 10.1097/01.TA.0000130613.35877.75 Savola, 2004, Effects of head and extracranial injuries on serum protein S100B levels in trauma patients, J Trauma, 56, 1229, 10.1097/01.TA.0000096644.08735.72 Petzold, 2003, CSF and serum S100B: Release and wash-out pattern, Brain Res Bull, 61, 281, 10.1016/S0361-9230(03)00091-1 Abraha, 1997, Serum S-100 protein, relationship to clinical outcome in acute stroke, Ann Clin Biochem, 34, 546, 10.1177/000456329703400510 Buttner, 1997, S-100 protein: Serum marker of focal brain damage after ischemic territorial MCA infarction, Stroke, 28, 1961, 10.1161/01.STR.28.10.1961 Elting, 2000, Comparison of serum S-100 protein levels following stroke and traumatic brain injury, J Neurol Sci, 181, 104, 10.1016/S0022-510X(00)00442-1 Missler, 1997, S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke, Stroke, 28, 1956, 10.1161/01.STR.28.10.1956 Foerch, 2003, S100B as a surrogate marker for successful clot lysis in hyperacute middle cerebral artery occlusion, J Neurol Neurosurg Psychiatry, 74, 322, 10.1136/jnnp.74.3.322 Wunderlich, 2004, Release of neurobiochemical markers of brain damage is related to the neurovascular status on admission and the site of arterial occlusion in acute ischemic stroke, J Neurol Sci, 227, 49, 10.1016/j.jns.2004.08.005 Foerch, 2004, Serum S100B predicts a malignant course of infarction in patients with acute middle cerebral artery occlusion, Stroke, 35, 2160, 10.1161/01.STR.0000138730.03264.ac Foerch, 2005, Evaluation of serum S100B as a surrogate marker for long-term outcome and infarct volume in acute middle cerebral artery infarction, Arch Neurol, 62, 1130, 10.1001/archneur.62.7.1130 Persson, 1987, S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: Markers of cell damage in human central nervous system, Stroke, 18, 911, 10.1161/01.STR.18.5.911 Aurell, 1991, Determination of S-100 and glial fibrillary acid protein concentration in cerebrospinal fluid after brain infarction, Stroke, 22, 1254, 10.1161/01.STR.22.10.1254 Lamers, 1995, Cerebrospinal neuron-specific enolase, S-100 and myelin basic protein in neurological disorders, Acta Neurol Scand, 92, 247, 10.1111/j.1600-0404.1995.tb01696.x Mokuno, 1983, Neuron-specific enolase and S-100 protein levels in cerebrospinal fluid of patients with various neurological diseases, J Neurol Sci, 60, 443, 10.1016/0022-510X(83)90155-7 Michetti, 1980, The S-100 antigen in cerebrospinal fluid as a possible index of cell injury in the nervous system, Neurol Sci, 44, 259, 10.1016/0022-510X(80)90133-1 Anderson, 2003, Biochemical markers of cerebrospinal ischemia after repair of aneurysms of the descending and thoracoabdominal aorta, J Cardiothorac Vasc Anesth, 17, 598, 10.1016/S1053-0770(03)00203-9 Petzold, 2003, A specific ELISA for measuring neurofilament heavy chain phospho-forms, J Immunol Methods, 278, 179, 10.1016/S0022-1759(03)00189-3 Green, 1997, A specific and sensitive ELISA for measuring S-100b in cerebrospinal fluid, J Immunol Methods, 205, 35, 10.1016/S0022-1759(97)00050-1 Keir, 1993, Cerebrospinal-fluid ferritin in brain necrosis–evidence for local synthesis, Clin Chim Acta, 216, 153, 10.1016/0009-8981(93)90148-W Wunderlich, 2006, Release of glial fibrillary acidic protein is related to the neurovascular status in acute ischemic stroke, Eur J Neurol, 13, 1118, 10.1111/j.1468-1331.2006.01435.x Stroick, 2006, Protein S-100B-a prognostic marker for cerebral damage, Curr Med Chem, 13, 3053, 10.2174/092986706778521751 Sargent, 2005, Structure/function overview of proteins involved in iron storage and transport, Curr Med Chem, 12, 2683, 10.2174/092986705774462969 Mazzini, 2007, Increased S100B serum levels in dilated cardiomyopathy patients, J Card Fail, 13, 850, 10.1016/j.cardfail.2007.07.009 McCabe, 2007, Antithrombotic and interventional treatment options in cardioembolic transient ischemic attack and ischemic stroke, J Neurol Neurosurg Psychiatry, 78, 14, 10.1136/jnnp.2006.092031 Girot, 2005, Secondary prevention after ischemic stroke: Evolution overtime in practice, J Neurol, 252, 14, 10.1007/s00415-005-0591-8 Ghanem, 2001, On the release and half-life of S100B protein in the peripheral blood of melanoma patients, Int J Cancer, 94, 586, 10.1002/ijc.1504 Petzold, 2007, CSF biomarkers for improved prognostic accuracy in acute CNS disease, Neurol Res, 29, 691, 10.1179/016164107X240080 Sen, 2005, Extracellular S100B in the injured brain: A highly sensitive surrogate marker for acute brain injury, Acta Scand Neuropathol, 147, 897